Several clinical trials have been reporting the positive effects of this approach on several indicators of glucose metabolism, including HOMA-IR, insulin levels, adiponectin, and resistin, in children and adolescents with obesity [134,135,136]. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.